Back to BNP PARIBAS FINANCIAL MARKETS BNP PARIBAS FINANCIAL MARKETS

REGNREGN
Showing 8 of 31 quarters

Position history for BNP PARIBAS FINANCIAL MARKETSBNP PARIBAS FINANCIAL MARKETS's holdings in REGENERON PHARMACEUTICALS

BNP PARIBAS FINANCIAL MARKETS holds 399,847 shares of REGN (REGENERON PHARMACEUTICALS), worth $249.3M as of 2026-Q2. The position was decreased (-10.8% shares). REGN represents 0.1% of BNP PARIBAS FINANCIAL MARKETS's portfolio.

Current Value

$249.3M

Current Shares

399,847

Total Value Change

-$61.2M

Total Shares Change

+104,435

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
399,847
-10.8%
$249.3M0.1%$623.54
0
2026-Q1
Increased
448,371
+1.7%
$346.4M0.2%$766.66
38
2025-Q4
Decreased
440,844
-7.7%
$340.3M0.2%$773.94
0
2025-Q3
Decreased
477,652
-8.9%
$268.6M0.1%$560.05
0
2025-Q2
Decreased
524,358
-29.8%
$275.3M0.2%$519.56
0
2025-Q1
Increased
746,613
+38.4%
$473.5M0.3%$634.66
49
2024-Q4
Increased
539,596
+82.7%
$384.4M0.2%$698.71
57
2024-Q3
Increased
295,412
+19.8%
$310.5M0.2%$1,036.94
44

Other major holders of REGN: VANGUARD GROUP INC, BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used